Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group.
about
The role of oxidative stress in Parkinson's diseaseSide effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyTolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trialsDopamine agonists in Parkinson's diseaseReview of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study.Nonergot dopamine-receptor agonists for treating Parkinson's disease - a network meta-analysis.Limitations of current Parkinson's disease therapy.The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.Drug selection and timing of initiation of treatment in early Parkinson's disease.Dopamine agonists in the treatment of Parkinson's disease.Role of dopamine agonists in Parkinson's disease: an update.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.Determination of minimal clinically important change in early and advanced Parkinson's disease.The frequency of cardiac valvular regurgitation in Parkinson's disease.Effects of pcDNA3-beta-NGF gene-modified BMSC on the rat model of Parkinson's disease.Early (Uncomplicated) Parkinson's Disease
P2860
Q24307946-3CADBA05-3C52-49FB-96D8-9A8568CF269FQ26738349-3A03EA4A-A455-4266-B411-6979F1FAB3FEQ28270780-E21DFFC1-C76F-4DBA-B182-AEE4A66FB309Q28276692-EDB06F04-32F2-42E7-BAC6-B13E1546557AQ33260250-9BC9F03B-D86D-43FF-AE22-BAD8FF54AF0AQ33591471-AD2F13CF-7A4A-4E6E-8623-EDE7AE2B9D9CQ33604937-29B25F58-060E-4A6E-93E2-CEE38A00C07BQ34187123-CE9FEE26-87B1-40C8-8B7D-95BE606B7E00Q34292471-21065180-236F-4F3D-B470-A59833AF100CQ34388170-F2FD81E0-4596-49AB-833C-15807D29D690Q34602815-57A2F2CA-625F-4E98-AF88-A6970DC1DE25Q36390870-424637A4-FD64-4612-922A-135A623EE354Q36972701-2FF502C6-CCBA-41C9-BBF2-83A062F42E92Q38070888-B554F042-F89C-4988-A36A-95AF1024C5DFQ42427666-995F5978-E99A-4C69-B51E-32CA689A644FQ42952856-DCA59557-B414-486E-B3DB-C71111651561Q44423669-DD8CD03F-A757-479E-9971-7C3CD5EA2ECAQ44778532-4383813B-DFD2-4509-B800-10B7179B1514Q46655840-32045F4C-50B2-4986-8384-F7431EDB8304Q50646263-D6D1DBE4-C674-444B-AFD7-791DB7097106Q58870319-4749ADE2-5F2A-49B6-BD72-5A4EF8B39D5F
P2860
Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@en
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@nl
type
label
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@en
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@nl
altLabel
Pergolide monotherapy in the treatment of early PD: A randomized, controlled study
@en
prefLabel
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@en
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@nl
P2093
P356
P1433
P1476
Pergolide monotherapy in the t ...... olide Monotherapy Study Group.
@en
P2093
Bermejo-Pareja F
Kulisevsky J
P304
P356
10.1212/WNL.53.3.573
P407
P577
1999-08-01T00:00:00Z